{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:00Z","timestamp":1787027040349,"version":"build-2736575974"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Synchronous primary carcinoma of the endometrium and ovary is rare in clinical practice. Distinguishing between synchronous primary carcinomas and metastatic carcinomas is very important for the selection of subsequent treatment regimens. In addition, triple primary malignancies are even rarer. Here, we report a case of synchronous triple primary malignancies, including primary carcinomas of the endometrium, ovary, and kidney.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a 60-year-old female patient who was diagnosed as synchronous primary carcinoma of the endometrium and ovary. Comprehensive staging surgery were performed. The molecular subtyping of endometrial cancer was mismatch repair deficiency. The whole-abdomen MRI was performed before the radiotherapy and a mass was found in the right renal parenchyma. The pathology showed papillary renal cell carcinoma. The result of germline genetic testing was negative (also negative for MLH1\u3001MSH2\u3001MSH6\u3001PMS2\u3001EPCAM). No recurrence or metastasis was observed during a 12-month follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case report adds to the limited literature on synchronous triple primary malignancies. For synchronous endometrial and ovarian cancer, distinguishing between primary tumors and metastases is clinically critical. Notably, the presence of MMRd subtype in such synchronous tumors does not inherently indicate Lynch syndrome. This case underscores the importance of integrating molecular testing and clinical manifestations to accurately diagnose multiple primary malignancies and formulate tailored treatment plans.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1668256","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:51:11Z","timestamp":1773211871000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Synchronous triple cancers of synchronous endometrial and ovarian carcinoma complicated by renal cancer: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Mu","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Gynecology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University","place":["Fuzhou, China"]},{"name":"College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhi","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University","place":["Fuzhou, China"]},{"name":"College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2009.03367.x","article-title":"Synchronous tumours of the female genital tract","volume":"56","author":"Singh","year":"2010","journal-title":"Histopathology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinomas\u2014a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study","volume":"83","author":"Zaino","year":"2001","journal-title":"Gynecologic Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000971","article-title":"Clinicopathological characteristics and prognostic factors of synchronous endometrial and ovarian cancers\u2014a single-institute review of 43 cases","volume":"27","author":"Jain","year":"2017","journal-title":"Int J Gynecological Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-011-2046-z","article-title":"Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas","volume":"285","author":"Rodolakis","year":"2012","journal-title":"Arch gynecology obstetrics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-019-0485-5","article-title":"Comparison and analysis of the clinicopathological features of SCEO and ECOM","volume":"12","author":"Wang","year":"2019","journal-title":"J Ovarian Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jog.12826","article-title":"Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers","volume":"41","author":"Sozen","year":"2015","journal-title":"J Obstetrics Gynaecology Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05288-5","article-title":"The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas","volume":"300","author":"Zhan","year":"2019","journal-title":"Arch Gynecology Obstetrics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/IGC.0000000000000600","article-title":"Synchronous primary cancers of the endometrium and ovary with the same histopathologic type versus endometrial cancer with ovarian metastasis: a single institution review of 72 cases","volume":"26","author":"Bese","year":"2016","journal-title":"Int J Gynecological Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Ruc","year":"2023","journal-title":"J Natl Compr Cancer Network"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0052","article-title":"NCCN Guidelines\u00ae Insights: ovarian cancer\/fallopian tube cancer\/primary peritoneal cancer, version 3.2024: featured updates to the NCCN guidelines","volume":"22","author":"Liu","year":"2024","journal-title":"J Natl Compr Cancer Network"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European association of urology guidelines on renal cell carcinoma: the 2025 update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur Urol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14923","article-title":"Endometrial Cancer Staging Subcommittee, FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynecology Obstetrics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113533","article-title":"Low-grade endometrioid endometrial cancer with adnexal only metastasis: evaluation of de-escalation of adjuvant therapy","volume":"200","author":"Matsuo","year":"2024","journal-title":"Eur J Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s0046-8177(85)80210-0","article-title":"Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases","volume":"16","author":"Ulbright","year":"1985","journal-title":"Hum pathology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199907000-00019","article-title":"Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament","volume":"527","author":"Scully","year":"1998","journal-title":"Am Registry Pathology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J Natl Cancer Institute"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32907","article-title":"Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome","volume":"147","author":"Reijnen","year":"2020","journal-title":"Int J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.03.005","article-title":"Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the \u03b2-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis","volume":"36","author":"Irving","year":"2005","journal-title":"Hum pathology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e6","article-title":"Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis","volume":"34","author":"Sakamoto","year":"2022","journal-title":"J Gynecologic Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001545","article-title":"Molecular and biological profile may discriminate between synchronous or metachronous endometrial and ovarian cancer","volume":"30","author":"Iacobelli","year":"2020","journal-title":"Int J Gynecological Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41379-020-00721-6","article-title":"Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes","volume":"34","author":"Moukarzel","year":"2021","journal-title":"Modern Pathology"},{"key":"B22","article-title":"Multiple primary Malignant tumors. A survey of the literature and a statistical study","volume":"16","author":"Warren","year":"1932","journal-title":"Am J cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: challenges and approaches, a review","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.01.005","article-title":"Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer","volume":"144","author":"Ryan","year":"2017","journal-title":"Gynecologic Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000985","article-title":"Clinicopathologic characteristics of endometrial cancer in Lynch syndrome: a French multicenter study","volume":"27","author":"Rossi","year":"2017","journal-title":"Int J Gynecological Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae011","article-title":"Testing region selection and prognostic analysis of MLH1 promoter methylation in colorectal cancer in China","volume":"12","author":"Tan","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.3802\/jgo.2019.30.e7","article-title":"Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma","volume":"30","author":"Yoneoka","year":"2019","journal-title":"J Gynecologic Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1668256\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:51:12Z","timestamp":1773211872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1668256\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":27,"alternative-id":["10.3389\/fonc.2026.1668256"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1668256","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1668256"}}